228 results
Page 4 of 12
6-K
EX-99.2
zk5hrq w91
10 May 21
Condensed Consolidated Interim Financial Statements of
4:48pm
6-K
EX-99.1
pigxu
10 May 21
Condensed Consolidated Interim Financial Statements of
4:48pm
6-K
EX-99.1
0fkgsf3i
10 May 21
BELLUS Health Reports First Quarter 2021 Financial Results and Business Highlights
4:30pm
6-K
EX-99.1
8f6pc9m8t9o
10 May 21
BELLUS Health to Present at the American Thoracic Society 2021 International Conference
7:03am
6-K
EX-99.2
i6ivfvh gg3rvg
9 Apr 21
Notice of Annual Meeting of Shareholders
12:00am
6-K
EX-99.1
apsro 6g6n
8 Apr 21
Bellus HEALTH 2020 ANNUAL REPORT
10:16am
6-K
EX-99.1
uoadf4n9z4faeh53vvj
24 Mar 21
BELLUS Health Appoints William Mezzanotte, MD, MPH to its Board of Directors
7:00am
40-F
EX-99.2
fb2pwh
25 Feb 21
Annual report (Canada)
4:58pm
40-F
EX-99.1
mfjnzz2qcwgmm91u
25 Feb 21
Annual report (Canada)
4:58pm
40-F
EX-99.3
dtwt8jcj6ml
25 Feb 21
Annual report (Canada)
4:58pm
6-K
EX-99.1
9dm8zsj
25 Feb 21
BELLUS Health Reports Year 2020 Financial Results and Business Highlights
4:02pm
6-K
EX-99.1
ospf8mdytepgb02a
23 Dec 20
Open Market Sale Agreementsm
5:06pm
SUPPL
jhjcq19gp8
23 Dec 20
Supplemental materials (foreign)
5:01pm
F-10/A
sys onw58
23 Dec 20
Registration of securities (Canada) (amended)
4:06pm
F-10
pan2up aenofnsdemq
14 Dec 20
Registration of securities (Canada)
4:18pm
6-K
EX-99.1
m06ia8w53 m801cjwku
8 Dec 20
BELLUS Health Announces First Patient Dosed in its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am
6-K
EX-99.1
4bg9my9da4789
7 Dec 20
Bellus Health Inc. 6-K
7:01am
6-K
EX-99.1
248c437uoc3qkube
12 Nov 20
Condensed Consolidated Interim Financial Statements of
4:09pm
6-K
EX-99.2
c47wmd
12 Nov 20
Condensed Consolidated Interim Financial Statements of
4:09pm
6-K
EX-99.1
tvfmp hk9ad
12 Nov 20
BELLUS Health Reports Third Quarter 2020 Financial Results and Business Highlights
7:01am